The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dose-efficacy relationship for molecularly targeted agents: A literature review of monotherapy phase I cancer clinical trials.
Jennifer Arrondeau
No relevant relationships to disclose
Xavier Paoletti
No relevant relationships to disclose
Marie-Paule Sablin
No relevant relationships to disclose
Simona Pop
No relevant relationships to disclose
Christophe Le Tourneau
No relevant relationships to disclose